Steve Gardner
Steve Gardner is a seasoned entrepreneur and an occasional angel investor specializing in informatics, with a focus on the life science industry.
Throughout his career, Steve has successfully raised over £65M in venture funding for various ventures and played a key role in designing, building, and launching innovative and successful products to support drug discovery and clinical informatics.
His extensive expertise spans technical, senior management, commercial, and corporate domains, acquired through leadership roles in start-ups, emerging companies, and Global Fortune 500 organizations.
Steve has a strong background in precision medicine, multi-omics analysis, protein structure modeling, computational chemistry, genomics for selective breeding, semantic data analysis, and commercialization strategies for high-tech products.
He has a proven track record of consulting for top life science companies, being involved in a London Stock Exchange flotation, and engaging in multiple corporate acquisitions.
With international experience in the UK, Europe, and the USA, Steve has published over 30 papers and holds 24 patents and applications as a principal inventor.
Steve Gardner holds a Doctor of Philosophy from the University of London (Birkbeck & UCL) and a Bachelor of Science from the University of Reading. Currently, he serves as the CEO of PrecisionLife Ltd and has held various leadership positions in notable organizations like Synomics Ltd, Ozo Innovations, and GenoKey Ltd.
His expertise and skills include a vast array of knowledge in informatics, life sciences, genomics, commercialization, marketing strategies, and novel hygiene solutions for the food industry.
